Bristol-Myers Squibb - 46 Year Stock Price History | BMY

Historical daily stock prices for Bristol-Myers Squibb since 1972 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Bristol-Myers Squibb (BMY) as of July 20, 2018 is 56.71.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $94.148B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.643B 16.14
Pfizer (PFE) United States $222.220B 13.67
Novartis AG (NVS) Switzerland $190.657B 16.36
Merck (MRK) United States $168.566B 15.06
AbbVie (ABBV) United States $141.089B 14.39
Novo Nordisk (NVO) Denmark $123.252B 20.42
Sanofi (SNY) France $106.218B 13.44
GlaxoSmithKline (GSK) United Kingdom $103.814B 14.19
Eli Lilly (LLY) United States $96.028B 19.07
AstraZeneca (AZN) United Kingdom $94.148B 9.86